Precision Optics Corporation, INC.: insider trades · United States · SEC (Form 4)

About Precision Optics Corporation, INC.

Precision Optics Corporation, Inc. (ticker: POCI) is a U.S.-based company listed on the Nasdaq Capital Market in the United States. It designs, develops, manufactures, and sells specialized optical and illumination systems and related components, with its business centered on the medical device and defense/aerospace markets. Founded in 1982 and publicly held since November 1990, the company is rooted in Massachusetts and has built a niche identity around advanced optical instruments, micro-optics, and highly miniaturized imaging solutions. For investors, POCI fits the profile of a small-cap, engineering-driven medical technology company whose results can be influenced by development-stage contracts, customer qualification timelines, and manufacturing ramp execution. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0000867840/000168316825007305/poci_i10k-063025.htm?utm_source=openai)) Precision Optics’ operating model is organized around four core activities: systems manufacturing, engineering and product development, Ross Optical components and assemblies, and its micro-optics laboratory. This structure gives the company a vertically integrated value chain spanning concept design, prototyping, regulatory and engineering support, and eventual production. In medical applications, the company develops and manufactures endoscopes, endocouplers, micro-medical cameras, micro-lenses, and custom imaging devices, including single-use solutions and 3D endoscopy systems aimed at minimally invasive surgery and surgical robotics. In defense and aerospace, the same miniaturization expertise is adapted to mission-critical optical applications where size and weight constraints matter, including certain satellite communications-related uses. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0000867840/000168316825007305/poci_i10k-063025.htm?utm_source=openai)) The company’s history is a key part of the investment case. Precision Optics was incorporated in Massachusetts in December 1982 and has operated as a public company since 1990. A major strategic step came in 2019, when it acquired the operating assets of Ross Optical Industries in El Paso, Texas, broadening its presence in custom optical components and assemblies. More recently, management launched the Unity Imaging Platform in January 2025, a modular CMOS endoscopic platform intended to support customizable imaging systems. In 2026, the company also reported a strong increase in quarterly revenue, driven mainly by systems manufacturing growth, although the micro-optics lab has experienced order timing delays tied to defense customers. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0000867840/000168316825007305/poci_i10k-063025.htm?utm_source=openai)) From a competitive standpoint, POCI is a specialist rather than a broad-based optics giant. Its differentiation lies in proprietary micro-optics know-how, custom design capability, integrated manufacturing, and the ability to serve demanding medical and defense clients with compact, high-performance optical systems. The company’s competitive edge is strongest where customers need highly customized, miniaturized imaging products that are difficult to source from mass-market suppliers. That said, investors should recognize the inherent risks of a niche business model: revenue can be lumpy, programs can shift between development and production at different speeds, and demand can vary materially by customer and end-market. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0000867840/000168316825007305/poci_i10k-063025.htm?utm_source=openai))